Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKesson
Cipla
QuintilesIMS
Moodys
Covington
Julphar
Merck
Healthtrust
Johnson and Johnson

Generated: January 17, 2018

DrugPatentWatch Database Preview

HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE Drug Profile

« Back to Dashboard

Which patents cover Hydrocodone Bitartrate And Chlorpheniramine Maleate, and when can generic versions of Hydrocodone Bitartrate And Chlorpheniramine Maleate launch?

Hydrocodone Bitartrate And Chlorpheniramine Maleate is a drug marketed by Acella Pharms Llc and Tris Pharma Inc and is included in two NDAs.

The generic ingredient in HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate; hydrocodone bitartrate. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorpheniramine maleate; hydrocodone bitartrate profile page.
Summary for HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE
Drug patent expirations by year for HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE

US Patents and Regulatory Information for HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acella Pharms Llc HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; hydrocodone bitartrate SOLUTION;ORAL 206891-001 Jun 9, 2017 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Tris Pharma Inc HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; hydrocodone bitartrate SOLUTION;ORAL 206438-001 Jan 27, 2015 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Novartis
Accenture
McKinsey
Colorcon
US Army
Harvard Business School
Chinese Patent Office
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot